Navigation Links
Transgenomic Awarded $1,070,453 From U.S. Government Under the Patient Protection and Affordable Care Act
Date:11/12/2010

OMAHA, Neb., Nov. 12, 2010 /PRNewswire/ --  Transgenomic, Inc. (OTC Bulletin Board: TBIO) today announced that it has been awarded a research and development grant totaling $1,070,453.32 from the U.S. government under HR: 3590 – Patient Protection and Affordable Care Act (the "Act") in immediately available funds. This is among the largest awards for any one company under the Act. Four of the Company's R&D programs received the highest maximum allowable award of $244,479.25 each, including COLD-PCR, the company's ultra-high mutation detection technology, Surveyor SCAN kit development for key cancer pathway gene mutations and mtDNA Damage Assays.

Under the Act, $1 billion was earmarked for qualifying therapeutic discovery projects that treat areas of unmet medical need or prevent, detect or treat chronic or acute diseases and conditions, and/or reduce the long-term growth of healthcare costs in the United States.  In addition, allocation of the credit took into consideration which projects show the greatest potential to create and sustain high-quality, high-paying U.S. jobs and to advance U.S. competitiveness in life, biological and medical sciences.  Applicants were required to submit detailed information demonstrating that their research conformed to the parameters of the Act, along with a summary of qualifying expenditures that formed the basis for the award.  The award of $1,070,453 represents a pro rata reduction applied to all applicants, as the program was significantly over-subscribed.

Craig Tuttle, president and chief executive officer of Transgenomic said, "We were particularly pleased that our work with COLD-PCR, an extremely sensitive method for detecting genetic mutations with, was recognized as being worthy of this development award as we see significant promise in applying COLD-PCR to the early detection of circulating
'/>"/>

SOURCE Transgenomic, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Transgenomic to Hold Third Quarter Financial Results Conference Call on November 15, 2010
2. Transgenomic Develops New Assays to Detect EGFR Mutations Using COLD-PCR
3. Dr. Eric Johnson Joins Transgenomic as Medical Director for Laboratory Services
4. Transgenomic Names Dr. Katherine Richardson Technical Director for Laboratory Services
5. Transgenomic Licenses IP From IntegraGen to Develop Genetic Test for Autism
6. Transgenomic Presents at 12th Annual BIO CEO & Investor Conference
7. Transgenomic Announces the Commercial Launch of SURVEYOR(R) Scan K-RAS Mutation Detection Kit
8. Transgenomic, Inc. Reports Third Quarter 2009 Results
9. Transgenomic and Power3 Medical Report Identification of Abnormal Serum Proteins in Parkinsons Disease
10. Transgenomic, Inc. Reports Second Quarter 2009 Results
11. Reminder: Transgenomic Inc. Announces Second Quarter 2009 Earnings Release Conference Call Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... The Academy of Model Aeronautics is pleased ... Indiana Gov. Mike Pence, has declared August 15, 2015, ... a Family Fest and aviation themed Motorcycle Rally in ... Wounded Warrior Project. , National Model Aviation Day has ... foremost organization for model aviation—to celebrate the history of ...
(Date:5/5/2015)... May 05, 2015 A comment period ... wide range of key photonics technologies – regulations that ... of U.S. industry. To help the community understand and ... May on the proposed changes to U.S. Munitions ... by International Traffic in Arms Regulations (ITAR). , For ...
(Date:5/5/2015)... , May 5, 2015  Orexigen Therapeutics, Inc. (Nasdaq: ... first quarter 2015 on Friday, May 8 before the ... live webcast and conference call at 8:30 a.m. Eastern ... call may be accessed by phone by calling (800) ... The webcast can be accessed live on the Investors ...
(Date:5/5/2015)... Synedgen Inc. is pleased to announce ... Manager. , Dr. Nguyen brings to Synedgen critical regulatory ... company as it moves forward in the FDA regulatory ... two years. Dr. Nguyen will lead the management of ... documents that must be completed in order to initiate ...
Breaking Biology Technology:State of Indiana proclaims August 15 as Model Aviation Day 2Comments needed now from photonics industry on revisions of U.S. export rules 2Comments needed now from photonics industry on revisions of U.S. export rules 3Comments needed now from photonics industry on revisions of U.S. export rules 4Synedgen Announces the Appointment of Regulatory Affairs Manager 2
... 28 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.,("Oncolytics") (TSX:ONC, ... interim results from a U.K. Phase Ia/Ib ... with advanced or,metastatic cancers is scheduled to ... (NCRI) conference on October 2, 2007 in ...
... Limited (NasdaqCM: PRAN) (ASX: PBT.AX), a biopharmaceutical,company ... treatments for,neurodegenerative disorders, today announced it has ... statements for the year ended,June 30, 2007, ... The annual,report its available on Prana,s website ...
... VaxGen,Inc. (Pink Sheets: VXGN) announced today that ... Directors as a result of accepting the CEO,position ... that Mr.,Anthony relinquish all corporate directorships in accepting ... (Logo: http://www.newscom.com/cgi-bin/prnh/19991112/VAXGENLOGO ) "On behalf of ...
Cached Biology Technology:Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial 2Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial 3Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial 4Jack Anthony to Resign From VaxGen's Board After Accepting CEO Position at Osprey Pharmaceuticals 2
(Date:3/24/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/hdgz7h/global_iris ) has ... Market 2015-2019" report to their offering. ... grow at a CAGR of 23.5 percent over the ... scenario and the growth prospects of the Global Iris ... market size, the report considers the revenue generated from ...
(Date:3/24/2015)... 24, 2015   Crossmatch ™, a leading ... that its U.are.U ® 4500 Fingerprint Readers ... Bros . to achieve PCI compliance for Point-of-Sale ... to the POS terminal, protecting the retailer and ... breaches. With one-third of worldwide ...
(Date:3/23/2015)... , March 23, 2015  In the 2014 fiscal ... case conviction losses. This figure accounts for a fraction ... to The Nilson Report, exceeds $11 billion globally. The ... after a crime has occurred. Investor Mark Saint ... expert Joe Paolella partnered to administer the ...
Breaking Biology News(10 mins):Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3
... tissue-engineered trachea (windpipe), utilising the patient,s own stem ... woman with a failing airway. The bioengineered trachea ... airway, thereby saving her life. These ... stem cells, combined with biologically compatible materials, can ...
... breakthrough against cancer, infectious diseases, or metabolic conditions like ... drugs, and even if they do clinical development usually ... medical research is conducted in highly fragmented groups focusing ... turn out not to work properly or to have ...
... created by a University of Central Florida professor show ... Professor James Turkson,s compounds disrupt the formation and spread ... The compounds, S3I-201 and S3I-M2001, break up a cancer-causing ... side effects so far. "The compounds are very ...
Cached Biology News:Adult stem cell breakthrough 2Adult stem cell breakthrough 3Systems biology brings hope of speeding up drug development 2Systems biology brings hope of speeding up drug development 3Two new compounds show promise for eliminating breast cancer tumors 2
... slides were designed to study protein expression patterns ... Tissue slices from three different species are ... be treated as a single histological slide for ... hybridization. This format allows a rapid analysis ...
... MacMelt software is used on ... melting profile of any DNA sequence ... in optimizing placement of primers and ... denaturing gradient gel electrophoresis (DGGE), constant ...
... Accurate To score SNPs, Polymorphic uses ... gold standard in DNA analysis. We use ... locus can be confirmed by sequencing in ... also provides sequence context information, further confirming ...
... Sub-Cell Model 192 and PowerPac basic power supply ... nucleic acids in agarose gels. This Model 192 ... 15 cm UV-transparent gel tray with fluorescent ruler, ... supply, 100-120 and 220-240 V, provides output of ...
Biology Products: